Back to search
Familial Dysbetalipoproteinemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Dysbetalipoproteinemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Familial Dysbetalipoproteinemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extre…
This pilot study investigates integrating whole genome sequencing and digital twin technology for managing hypercholesterolemia in Abu Dhabi clinics. It aims to…
ACCURATE will test the hypothesis that opportunistic genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coron…
Provide compassionate use of evinacumab
To date, there are highly effective lipid-lowering drugs, the combination of which makes it possible to achieve the target level of LDL-C in most patients with…